Citigroup Inc Sangamo Therapeutics, Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Citigroup Inc holds 3,239 shares of SGMO stock, worth $4,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,239

Previous 24,660 86.87%

Holding current value

$4,437

Previous $8,000 75.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.32 - $1.1 $6,854 - $23,563	-21,421 Reduced 86.87%	3,239 $2,000
Q2 2024 Aug 12, 2024	SELL	$0.36 - $0.65 $2,512 - $4,537	-6,980 Reduced 22.06%	24,660 $8,000
Q1 2024 May 10, 2024	BUY	$0.42 - $1.38 $1,309 - $4,304	3,119 Added 10.94%	31,640 $21,000
Q4 2023 Feb 09, 2024	BUY	$0.3 - $0.63 $7,802 - $16,384	26,007 Added 1034.49%	28,521 $15,000
Q3 2023 Nov 09, 2023	SELL	$0.58 - $1.47 $25,214 - $63,906	-43,474 Reduced 94.53%	2,514 $1,000
Q2 2023 Aug 10, 2023	SELL	$1.11 - $1.74 $630,929 - $989,024	-568,405 Reduced 92.51%	45,988 $59,000
Q1 2023 May 11, 2023	BUY	$1.66 - $3.67 $456,197 - $1.01 Million	274,818 Added 80.93%	614,393 $1.08 Million
Q4 2022 Feb 09, 2023	SELL	$2.77 - $5.07 $160,003 - $292,858	-57,763 Reduced 14.54%	339,575 $1.07 Million
Q3 2022 Nov 10, 2022	BUY	$4.27 - $6.39 $216,296 - $323,685	50,655 Added 14.61%	397,338 $1.95 Million
Q2 2022 Aug 10, 2022	BUY	$3.28 - $6.21 $725,267 - $1.37 Million	221,118 Added 176.1%	346,683 $1.44 Million
Q1 2022 May 12, 2022	SELL	$5.23 - $7.82 $1.25 Million - $1.87 Million	-238,505 Reduced 65.51%	125,565 $730,000
Q4 2021 Feb 10, 2022	BUY	$7.29 - $10.97 $972,172 - $1.46 Million	133,357 Added 57.8%	364,070 $2.73 Million
Q3 2021 Nov 10, 2021	BUY	$9.01 - $12.01 $2.08 Million - $2.77 Million	230,713 New	230,713 $2.08 Million

Others Institutions Holding SGMO

# of Institutions

115

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $214M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account